We are live on ! Find out more
CCC

Crescent Capital Consulting Portfolio holdings

AUM $607M
1-Year Est. Return 22.88%
This Fund
S&P 500
This Quarter Est. Return
+8.85%
1 Year Est. Return
+22.88%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$607M
AUM Growth
+$61.5M
Cap. Flow
+$25.7M
Cap. Flow %
4.23%
Top 10 Hldgs %
39.81%
Holding
643
New
50
Increased
104
Reduced
60
Closed
115

Sector Composition

Rank Sector Weight
1 Miscellaneous 72.8%
2 Technology 5.49%
3 Healthcare 4.4%
4 Consumer Staples 3.49%
5 Materials 3.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WY icon
401
Weyerhaeuser
WY
$16.6B
$8K ﹤0.01%
200
ZBH icon
402
Zimmer Biomet
ZBH
$18.7B
$8K ﹤0.01%
62
HEP
403
DELISTED
Holly Energy Partners, L.P.
HEP
$8K ﹤0.01%
500
BBY icon
404
Best Buy
BBY
$19B
$7K ﹤0.01%
66
CCL icon
405
Carnival Corporation Ltd
CCL
$32.2B
$7K ﹤0.01%
354
CLX icon
406
Clorox
CLX
$11.3B
$7K ﹤0.01%
42
STEW
407
SRH Total Return Fund
STEW
$1.78B
$7K ﹤0.01%
500
VEEV icon
408
Veeva Systems
VEEV
$44.5B
$7K ﹤0.01%
26
CTSH icon
409
Cognizant
CTSH
$28.1B
$6K ﹤0.01%
63
DECK icon
410
Deckers Outdoor
DECK
$11.7B
$6K ﹤0.01%
96
EBAY icon
411
eBay
EBAY
$46B
$6K ﹤0.01%
92
NKE icon
412
Nike
NKE
$57B
$6K ﹤0.01%
38
OSK icon
413
Oshkosh
OSK
$9.7B
$6K ﹤0.01%
52
SPG icon
414
Simon Property Group
SPG
$67.8B
$6K ﹤0.01%
40
SYF icon
415
Synchrony
SYF
$26B
$6K ﹤0.01%
136
VMEO
416
DELISTED
Vimeo
VMEO
$6K ﹤0.01%
313
BERY
417
DELISTED
Berry Global Group, Inc.
BERY
$6K ﹤0.01%
85
CDK
418
DELISTED
CDK Global, Inc.
CDK
$6K ﹤0.01%
160
BIO icon
419
Bio-Rad Laboratories Class A
BIO
$10.3B
$5K ﹤0.01%
6
DVA icon
420
DaVita
DVA
$11.7B
$5K ﹤0.01%
44
IPG
421
DELISTED
Interpublic Group of Companies
IPG
$5K ﹤0.01%
135
JBL icon
422
Jabil
JBL
$32.5B
$5K ﹤0.01%
67
PHM icon
423
Pultegroup
PHM
$23.7B
$5K ﹤0.01%
86
RIVN icon
424
Rivian
RIVN
$22.8B
$5K ﹤0.01%
+50
New +$5.76K
TRIP icon
425
TripAdvisor
TRIP
$1.09B
$5K ﹤0.01%
193

Similar funds

Crescent Capital Consulting's Q4 2021 Portfolio in Review

As of Q4 2021, Crescent Capital Consulting held 643 positions worth $607M, up 11% from $546M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Crescent Capital Consulting deployed $25.7M of net new capital in Q4 2021, opening 50 new positions and adding to 104 existing holdings. Its largest new stake was Invesco BulletShares 2024 High Yield Corporate Bond ETF: 454,682 shares worth $11.4M.

By sector, the portfolio is most concentrated in Miscellaneous at 73% of assets, down from 75% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was iShares MSCI ACWI ex US ETF, an estimated $8.26M trimmed.

  • Crescent Capital Consulting's largest Q4 2021 buy was Invesco BulletShares 2024 High Yield Corporate Bond ETF: 454,682 shares worth $11.4M.
  • Crescent Capital Consulting added most to iShares TIPS Bond ETF in Q4 2021, an estimated $12.1M increase.
  • Crescent Capital Consulting's biggest Q4 2021 reduction was iShares MSCI ACWI ex US ETF, cutting an estimated $8.26M.
  • Crescent Capital Consulting fully exited iShares iBonds 2023 Term High Yield and Income ETF in Q4 2021, selling an estimated $297K.
  • Crescent Capital Consulting's ten largest holdings make up 40% of its $607M portfolio in Q4 2021.
  • Crescent Capital Consulting opened 50 new positions and closed 115 in Q4 2021.
  • Crescent Capital Consulting's portfolio value rose 11% quarter-over-quarter to $607M.

Based on Crescent Capital Consulting's 13F filing for Q4 2021, filed 18 Jan 2022.